Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01406795 · ClinicalTrials.gov registry record · NA

The GORE Viabahn Endoprosthesis for the Treatment of Venous Occlusions and Stenoses

A NA study, sponsored by Stanford University.

Terminated
Registry status
NA
Development phase
1
Enrollment target

NCT01406795: Clinical Trial NA study, sponsored by Stanford University.

NCT01406795 is a NA study that was terminated before completion, run by Stanford University. The registered enrollment target is 1 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT01406795, a NA study, was terminated before completion, sponsored by Stanford University.

TERMINATED
Registry status
NA
Development phase
1 participants
Enrollment target

Study Summary

To study the safety and efficacy of drug coated stents for the treatment of venous occlusions and stenoses in the lower extremity. The use of the device for the treatment of peripheral arterial disease is approved by the FDA, however, the use of the device in venous occlusions and stenoses, although performed by some practitioners, has not yet been studied in detail.

Primary Outcome

Stent migration is reported as the count of participants with stent migration within 1 month following stent placement.

Interventions

  • DEVICE Gore Viabahn Heparin Coated Stent

Trial Details

FieldValue
Enrollment Target 1 participants
Start Date 2010-12
Est. Completion 2014-12
Phase NA
Stanford University

1,744 total trials

Why NCT01406795 stopped before completion

NCT01406795 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).

The record links to 0 conditions, and to 1 intervention - of which Gore Viabahn Heparin Coated Stent is the first listed.

NCT01406795 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01406795 about?

NCT01406795 is a clinical study titled "The GORE Viabahn Endoprosthesis for the Treatment of Venous Occlusions and Stenoses". To study the safety and efficacy of drug coated stents for the treatment of venous occlusions and stenoses in the lower extremity. The use of the device for the treatment of peripheral arterial disease is approved by the FDA, however, the use of the device in venous occlusions and stenoses, although...

What is the current status of trial NCT01406795?

This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2010-12. Estimated completion is 2014-12.

What interventions are being tested in trial NCT01406795?

The interventions under investigation include: Gore Viabahn Heparin Coated Stent (DEVICE).

Who is sponsoring clinical trial NCT01406795?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01406795's enrollment target sits among peer trials

1 2001st of 2000 the lowest of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01406795, the US trial registry maintained by the National Library of Medicine. NCT01406795 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.